Brain Cancer Market Report 2034: Epidemiology Insights, Pipeline Developments, and Key Regulatory Approvals (FDA, EMA, PMDA) | Published by DelveInsight | Featurin…

February 2024: Servier announced FDA acceptance and priority review of the NDA for vorasidenib, which could become the first ...
The Debrief

Neuralink Captures Wall Street’s Eye, Sparks Debate Over Brain Interfaces and Future “Neuro Elite”

A new report examines how Wall Street is turning its attention toward deep tech and bioscience, specifically BCI companies ...
The Debrief

Neuralink Submits First Human Clinical Data for Peer Review, Marking Milestone in Brain-Computer Interface Research

Neuralink has moved to validate its controversial brain-implant technology in the scientific arena by submitting its first ...
News Medical on MSN

Molecular basis of Long Covid's “brain fog” uncovered

Long Covid is a chronic condition that causes cognitive problems known as “brain fog,” but its biological mechanisms remain ...